Intelligent Bio Solutions Inc. (INBS) stock
INBSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 11/3057% below fair value
$1.56+0.06 (+4.00%)
Close on Nov 17, 2026Market cap $4.72MP/E –Yield –
Intelligent Bio Solutions total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Intelligent Bio Solutions's total debt was $150.43K at Mar 31, 2024. For fiscal 2023 it was $402.86K.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Jun 30, 2023 | $402.86K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $150.43K | -68.1% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $230.97K | -54.5% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $306.23K | – |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $402.86K | – |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $470.87K | – |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $507.40K | – |
See a number that looks wrong?